Takara Bio USA, Inc.
Takara Bio USA, Inc., a subsidiary of Takara Bio Inc., is a leading player in the biotechnology industry, headquartered in Japan. Established in 2000, the company has made significant strides in the fields of molecular biology, genomics, and cell biology, with major operational regions across North America and Europe. Specialising in innovative products and services, Takara Bio USA offers a diverse range of solutions, including high-quality reagents, kits, and instruments for research and clinical applications. Their unique offerings, such as the SMARTer™ technology for RNA sequencing and the In-Fusion™ cloning system, set them apart in the competitive landscape. With a strong market position, Takara Bio USA is recognised for its commitment to advancing scientific research and has achieved numerous milestones, including collaborations with leading research institutions. Their dedication to quality and innovation continues to drive their success in the biotechnology sector.
DitchCarbon Score
How does Takara Bio USA, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Takara Bio USA, Inc.'s score of 21 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Takara Bio USA, Inc.'s reported carbon emissions
In 2023, Takara Bio USA, Inc. reported total carbon emissions of approximately 66486000 kg CO2e from Scope 1, 20468000 kg CO2e from Scope 2, and 754409000 kg CO2e from Scope 3 emissions. This represents a significant portion of their overall carbon footprint, with Scope 3 emissions being the largest contributor, primarily from purchased goods and services, which accounted for about 564630000 kg CO2e. In 2022, the company recorded emissions of approximately 69280000 kg CO2e for Scope 1, 21522000 kg CO2e for Scope 2, and 802323000 kg CO2e for Scope 3. The data indicates a slight reduction in Scope 1 and Scope 2 emissions in 2023 compared to 2022, while Scope 3 emissions also decreased. Despite these figures, Takara Bio USA, Inc. has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of defined reduction strategies suggests a need for further commitment to climate action within the industry context. Overall, the company’s emissions data highlights the importance of addressing both direct and indirect emissions to achieve meaningful climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 6,822,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 4,039,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 3,000,000 | 0,000,000 | 0,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Takara Bio USA, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
